Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04784416Phase 2Active Not Recruiting

Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)

Role: collaborator

NCT02959307Not ApplicableCompleted

Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)

Role: collaborator

NCT03437967Not ApplicableTerminated

Effect of LASER Photobiomodulation Therapy on Chronic Pain and Opioid Weaning

Role: lead

NCT02328911Phase 2Withdrawn

Laser Therapy for Diabetic Peripheral Neuropathic Pain

Role: collaborator

All 4 trials loaded